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Abstract Peroxynitrite, formed by combination of superoxide 
radical with nitric oxide, is a reactive tissue-damaging species 
apparently involved in the pathology of several human diseases. 
Peroxynitrite nitrates tyrosine residues and inactivates vq-anti- 
proteinase. We show that both lipoic acid and dihydrolipoic acid 
efficiently protect against damage by peroxynitrite. By contrast, 
other disulphides tested did not. The biological antioxidant effects 
of lipoateldihydrolipoate may involve scavenging of reactive ni- 
trogen species as well as reactive oxygen species. 
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1. Introduction 
The metabolic role of lipoamide as a cofactor in the pyruvate 
and ~-ketoglutarate multienzyme complexes is well-known 
[1,2]. More recently, however, considerable attention has been 
given to possible antioxidant functions for ~-lipoic acid and its 
reduced form, dihydrolipoate [3]. It is well-known that various 
reactive oxygen species such as superoxide radical, hydrogen 
peroxide, hydroxyl radical and hypochlorous acid are formed 
in vivo and contribute to tissue injury in human disease [4]. 
Hence the established ability [3,5-8] of lipoate/dihydrolipoate 
to scavenge some of these species, plus its relative lack of 
toxicity, may make it a therapeutically-useful antioxidant [3]. 
Recently, there has been considerable interest in reactive 
nitrogen species as mediators of tissue injury [9,10]. Although 
nitric oxide (NO') has many important physiological functions 
[11], its production in excess may contribute to the pathology 
of neurodegenerative disease, chronic inflammation, acute res- 
piratory distress syndrome, atherosclerosis and septic shock 
[9-14]. Part of the toxicity of NO" involves its reaction with 
superoxide radical (02 °-) to give peroxynitrite, ONOO- 
O2"- + NO" --~ ONOO- (1) 
Peroxynitrite induces peroxidation of lipids, oxidizes methion- 
ine and -SH residues in proteins, depletes antioxidants and 
causes DNA damage [9,10,15,16]. In particular, addition of 
peroxynitrite to biological fluids leads to nitration of tyrosine 
residues, and the presence of these appears to be a 'marker' of 
peroxynitrite-dependent damage in vivo [10,12-16]. Tyrosine 
nitration can interfere with signal transduction mechanisms 
involving phosphorylation/dephosphorylation [17]. Peroxyni- 
trite also inactivates ~-antiproteinase, the major inhibitor of 
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serine proteases (such as elastase) in human body fluids [15,18]. 
Hence peroxynitrite generation in vivo can facilitate both oxi- 
dative and proteolytic damage [9,10,18]. 
In the present paper, we show that both cMipoic acid and 
dihydrolipoic acid are very powerful scavengers of ONOO-, 
able to protect yrosine against nitration and ~-antiproteinase 
against inactivation by ONOO-. 
2. Materials and methods 
2.1. Reagents 
N-Succinyl(Ala)3 p-nitroanilide (SANA), Dc-tyrosine, elastase 
(E2058), cq-antiproteinase (A0924), Dc-tyrosine (type T-3379), GSH 
(type G-4241), N-acetylcysteine (A-8199), GSSG (G-6654), methionine 
(M-9500), DL-penicillamine (P-5125) and penicillamine disulphide (P- 
1271) were from Sigma, Poole, Dorset, UK. Dihydrolipoic (DHLA) 
and lipoic acids were a kind gift from Asta Medica. 
2.2. Peroxynitrite synthesis 
An acidic solution (0.6 M HCI) of H202 (0.7 M) was mixed with 
KNO2 (0.6 M) on ice for one second and the reaction quenched with 
ice-cold NaOH (1.2 M). The concentration f the resultant stock was 
measured spectrophotometrically at 302 nm [10]. The stock was then 
frozen overnight (- 200C) and the top layer of the solution collected for 
the experiment [10]. 
2.3. Measurement of tyrosine nitrath~n 
A stock concentration (10 mM) of DL-tyrosine was prepared in 10 ml 
by adding 8 ml of water to 250/11 of 10% (w/v) KOH followed by 250 
/~1 of 5% phosphoric acid with 1.5 ml of water. 0.1 ml of tyrosine 
solution together with 0.1 ml of a solution of the compound to be tested 
was added to a plastic test tube containing 0.795 ml of buffer (500 mM 
KzHPOdKH2PO4 pH 7.4) and incubated in a water bath at 37°C for 
15 min. After this time peroxynitrite (typically 5 ~tl) was added to a final 
concentration f 1 mM, the tubes vortexed for 15 s and incubated for 
a further 15 min. The pH was measured after the addition of peroxyni- 
trite and found to be 7.4-7.5. 
Measurement of 3-nitrotyrosine was performed essentially as in [19] 
using a Spherisorb 5 /lm ODS2 C~8 column (HPLC Technology, 
Wellington House, Cheshire, England, UK) with a guard column C~8 
cartridge (Hibar from BDH, Poole, England, UK). The eluent was 500 
mM KH2POa/H3PO4 pH 3.01, with 20% methanol (v/v) at a flow rate 
of 1 ml • rain ~ through a Polymer Laboratories pump (Essex Road, 
Church Strotten, Shropshire, England, UK) and UV detector set at 274 
nm (sensitivity 0.02). The 3-nitrotyrosine d tected was confirmed by 
spiking with standards. Peak heights of tyrosine and 3-nitrotyrosine 
were measured and concentrations calculated from a standard curve. 
2.4. Prevention of eq-antiproteinase &activation 
Elastase and cfl-antiproteinase were measured essentially as de- 
scribed in [20]. ~-Antiproteinase was dissolved in phosphate-buffered 
saline, pH 7.4 (140 mM NaC1, 2.7 mM KCI, 16 mM Na2HPO4, 2.9 mM 
KH2PO4) to a concentration f 4 mg/ml and elastase in the same buffer 
to 5 mg/ml. The volume of cqAP needed to inhibit elastase 80~90% 
(typically 6~70 ,ul) was added to buffer (500 mM K2HPO4/KH2PO4, 
pH 7.4) with or without 0.1 of ml compound to be tested to give a 
volume of 0.945 ml and incubated in a water bath at 37°C for 15 min, 
when peroxynitrite (typically 5~tl) was added to a final concentration 
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of 0.5 mM. The sample was vortexed for 10 seconds and incubated for 
5 min. Then elastase (typically 50/Jl) was added and the sample incu- 
bated at 37°C for a further 15 min. Then 0.1 ml of elastase substrate 
(SANA) was added and the rate of reaction followed at 410 nm for 30 s. 
3. Results 
3.1. Inactivation of ~-antiproteinase 
As expected [18], addition of ONOO- to ~t-antiproteinase 
(~AP) led to inactivation of the ability of ¢xAP to inhibit 
elastase. Inactivation increased with ONOO- concentration 
and the reaction was complete within 5 min at pH 7.4 (data not 
shown). A 5 min incubation time with 0.5 mM ONOO- was 
selected for further studies. If the ONOO- solution was added 
to the buffer and incubated for 5 min at 37°C before adding 
~AP the resulting 'decomposed ONOO-'  [10] solution had no 
effect on etAP. 
Fig. 1 (column A) shows the activity of uninhibited elastase. 
Addition of ¢~AP markedly decreased elastase activity (column 
B) but pre-incubation of etAP with ONOO- largely destroyed 
its elastase-inhibitory capacity (column C). Several thiols and 
disulphides were tested, at a concentration two-fold excess over 
ONOO-, for ability to prevent inactivation of :z~AE Methion- 
ine was protective, probably because inactivation of ¢IAP in- 
volves damage to an essential methionine residue. Thiols (pen- 
icillamine, GSH, N-acetylcysteine) were generally protective 
whereas disulphides (GSSG, penicillamine disulphide) were 
much less so. By contrast, both dihydrolipoic acid (DHLA) and 
lipoic acid (LA) were highly protective. Fig. 2 shows the con- 
centration-dependence of this effect. LA and DHLA could 
protect ~tAP effectively even at concentrations much lower 
than those of ONOO-, indicating that one molecule of these 
compounds can scavenge several ONOO- molecules. 
3.2. Inhibition of tyrosine nitration 
When tyrosine is exposed to ONOO- at physiological pH, 
nitration occurs [10,12,13,16,17]. Fig. 3 shows that several thiol 
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Fig. 1. A screen of thiols and disulphides for ability to protect ~tAP 
against inactivation by peroxynitrite. The test compound at a final 
concentration of 1 mM was mixed with ~AP before addition of 
ONOO- (final concentration 0.5 mM). For further details ee section 
2. Control experiments showed that none of the compounds had any 
effect on elastase itself, nor on the ability of ~AP to inhibit elastase, 
nor could they reactivate cqAP after it had been inactivated by ONOO-. 
Results are mean + S.E.M. of 4 or more experiments. 
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Fig. 2. Concentration-dependence of the protective ffects of lipoic 
acid, DHLA, methionine, GSH and GSSG against inactivation of0qAP 
by ONOO-. Compounds were added to give the final concentrations 
stated. For further experimental details ee legend to Fig. 1. Results are 
mean + S.E.M. of 4 or more experiments. 
compounds (GSH, DHLA and penicillamine) could prevent 
this nitration whereas the disulphides GSSG and penicillamine 
were much less effective. By contrast, lipoic acid was almost as 
protective as DHLA. As observed with the cqAP studies re- 
ported above, LA and DHLA could prevent yrosine nitration 
even at concentrations much lower than those of ONOO-, 
indicating that one molecule of these compounds can scavenge 
several ONOO- molecules. 
4. Discussion 
Peroxynitrite generation i vivo is being implicated in a wide 
range of human diseases, including atherosclerosis [13], lung 
disease [12], neurodegenerative disorders [9] and chronic in- 
flammation [14,21]. Hence agents able to protect against 
ONOO--dependent damage may be therapeutically useful. Thi- 
ols are already known to be good scavengers of ONOO 
[10,15,16] and we show here that DHLA is very effective, able 
to protect ~jAP against inactivation by ONOO- and to prevent 
nitration of tyrosine by this species. The presence of two -SH 
groups in DHLA may explain why it is more effective, on a 
molar basis, than GSH or N-acetylcysteine in protecting 
against s tAP inactivation (Figs. 1 and 2). It is of special interest, 
however, that (unlike the other disulphides tested), LA is com- 
parably protective. ~-Lipoic acid is readily absorbed from the 
diet and converted to DHLA in vivo, but this conversion may 
be only partial [3]. The high reactivity of LA may be due to its 
strained cyclic disulphide moiety [3,22]. Hence LA and DHLA 
may exert significant antioxidant activities in vivo not only 
because of their ability to scavenge reactive oxygen species [3] 
but also because they can prevent damage by reactive nitrogen 
species. 
Our data do not necessarily mean that LA and DHLA are 
acting by directly scavenging ONOO : they could instead be 
combining with reactive intermediates of peroxynitrite decom- 
position. Although inactivation of ~tAP may involve direct 
attack on methionine residues by ONOO [18], nitration of 
tyrosine by ONOO- is a complex reaction that may involve 
such species as NO2 ° and NO/  [10,23]. Hence scavenging of 
these species could also account for the actions of LA and 
DHLA. 
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Fig. 3. Prevention of peroxynitrite-dependent nitration of tyrosine by 
thiols and disulphides. Tyrosine (1 mM) was incubated with 1 mM 
ONOO- as described in section 2. Compounds were added to give the 
final concentrations stated. Results are mean + S.E.M. of 4 or more 
experiments. 
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